Revenue Growth and Acceleration
Net sales increased 2.9% at constant exchange rates to CHF 11.1 billion in 2025, with stronger acceleration in H2 (3.6% growth) and organic net sales growth of 2.5% (H1 2.1% → H2 3.6%).
Core EBIT Expansion
Core EBIT rose to CHF 349 million, up 6.7% year-on-year, with core EBIT margin improving from 3.1% to 3.2% (+0.1 percentage points). Organic core EBIT growth was 5%, twice the rate of organic net sales.
Very Strong Cash Generation
Free cash flow of CHF 215.5 million with cash conversion of 95.2% — the sixth consecutive year above the 90% target — supported a positive net cash position and disciplined capital allocation.
Accelerated M&A Activity and Capital Return
Announced 9 accretive M&A transactions in 2025 (part of a total of 35 acquisitions between 2019–2025 vs 16 between 2012–2019). Board proposed ordinary dividend increased to CHF 2.50 per share (+6.4%), marking the 13th consecutive annual increase; 5‑year average dividend growth ~5.1%.
Healthcare Business Outperformance
Healthcare (largest BU) grew net sales 4.6% to CHF 5.8 billion. Core EBIT reached CHF 174.2 million with a core EBIT margin of 3%, marking the fourth consecutive year of margin improvement and a growing share of higher‑value commercial outsourcing (55%).
Consumer Goods Recovery in H2
Consumer Goods net sales +1.2% for the year and accelerated +2.8% in H2. Core EBIT increased to CHF 89.7 million (+5.4%), with a ~10 basis point margin expansion and very strong H2 momentum (core EBIT growth ~14% in past 6 months; H2 core EBIT margin ~3%).
Performance Materials Resilience in Asia
Performance Materials net sales +1.4% to CHF 1.4 billion; Asia Pacific (≈60% of BU sales) grew 5.5%. Core EBIT up 1.9%, core EBIT margin improved to 8.2%, and core EBITA reached CHF 120.4 million (core EBITA margin 8.9%), supported by pricing discipline and 3 acquisitions.
Technology BU Strategic Moves and Digital Growth
Technology delivered results around 2024 levels amid macro uncertainty while completing 5 strategic Scientific Solutions acquisitions, divesting non‑core cable businesses, and achieving strong digital sales growth.
Operational Efficiency and Cost Savings
Logistics & distribution costs reduced by ~CHF 35 million over five years, contributing ~30 basis points to core EBIT margin improvement. Low capex (0.3%–0.5% of net sales) and optimized working capital (matching 8.6% of sales two years ago) reinforced asset‑light model.
Multi‑year Financial Improvements
5‑year CAGR: net sales +4.2% and core EBIT +11.6%. Core conversion (core EBIT as % of gross profit) rose to 21.4% (+70 bps over prior year), and core EBIT margin up 60 bps over five years to 3.2%. Core ROE 12.4% (+30 bps) and improved equity ratio to 33.1%.